Low expression of the proteins involved in glucose utilization in Ph+ B-ALL is most likely due to residual activity of both PAX5 and IKZF1 in Ph+ B-ALL, as the vast majority of their inactivating mutations in Ph+ B-ALL are monoallelic [53,59]. The gene discussed is PAX5; the disease is acute lymphoblastic leukemia.